Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Profit After Tax (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Profit After Tax for 3 consecutive years, with -$34.2 million as the latest value for Q1 2026.

  • Quarterly Profit After Tax fell 58.85% to -$34.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$144.8 million through Jan 2026, down 72.32% year-over-year, with the annual reading at -$113.8 million for FY2025, 20.92% down from the prior year.
  • Profit After Tax for Q1 2026 was -$34.2 million at Kestra Medical Technologies, down from -$32.8 million in the prior quarter.
  • The five-year high for Profit After Tax was -$19.9 million in Q3 2024, with the low at -$52.1 million in Q2 2025.
  • Average Profit After Tax over 3 years is -$27.8 million, with a median of -$22.3 million recorded in 2024.
  • Peak annual rise in Profit After Tax hit 0.51% in 2025, while the deepest fall reached 133.59% in 2025.
  • Over 3 years, Profit After Tax stood at -$20.4 million in 2024, then plummeted by 60.96% to -$32.8 million in 2025, then fell by 4.21% to -$34.2 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods came in at -$34.2 million, -$32.8 million, and -$25.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.